Taghizadeh Afshari Ali, Mohammadi Fallah Mohammad Reza, Alizadeh Mansour, Makhdoomi Khadijeh, Rahimi Ezatollah, Vossoghian Sara
Department of Nephrology, Nephrology and Kidney Transplant Research Center, Urmia University of Medical Sciences, Urmia, Iran.
Iran J Kidney Dis. 2016 Mar;10(2):85-90.
Receiving a kidney transplant from donors with multiple renal arteries (MRAs) is suggested to be associated with higher risk of vascular and urologic complications and poor allograft outcomes compared to the donors with single renal artery (SRA). We evaluated survival rates in the recipients from donors with MRAs compared to those from donors with SRA.
In a retrospective study on 115 kidney allograft recipients, demographic characteristics and the outcomes of kidney transplantation were compared between the recipients from donors with MRAs compared to those from donors with SRA. These included acute tubular necrosis, acute allograft rejection, hypertension, vascular complications, urologic complications, kidney function indicators, and allograft survival at 1 year.
There was no significant difference in the recipients' age, sex distribution, and weight, donors' age, donor-recipient familial relation, urologic complications, and duration of hospitalization between the two groups. However, MRA was significantly associated with a higher likelihood of right-side kidney donation, longer warm and cold ischemia times, and lower glomerular filtration rate and higher serum creatinine concentrations at discharge and 12 months after transplantation, as compared to SRA transplants. No significant difference was seen in late complications including hypertension and renal artery stenosis. One-year graft survival was slightly poorer in the MRA group than the SRA group.
Our results demonstrate that kidney allografts with MRAs are associated with risks but have acceptable outcomes during the 1st year after transplantation, as compared to SRA kidney allografts.
与接受单支肾动脉(SRA)供体的肾移植受者相比,接受多支肾动脉(MRA)供体的肾移植被认为与血管和泌尿系统并发症的风险更高以及移植肾预后较差有关。我们评估了接受MRA供体的受者与接受SRA供体的受者的生存率。
在一项对115例肾移植受者的回顾性研究中,比较了接受MRA供体的受者与接受SRA供体的受者的人口统计学特征和肾移植结果。这些包括急性肾小管坏死、急性移植肾排斥反应、高血压、血管并发症、泌尿系统并发症、肾功能指标以及1年时的移植肾存活率。
两组受者的年龄、性别分布和体重、供者年龄、供受者家族关系、泌尿系统并发症以及住院时间均无显著差异。然而,与SRA移植相比,MRA与右侧肾脏供体的可能性更高、热缺血和冷缺血时间更长、出院时以及移植后12个月时肾小球滤过率更低和血清肌酐浓度更高显著相关。在包括高血压和肾动脉狭窄在内的晚期并发症方面未观察到显著差异。MRA组的1年移植肾存活率略低于SRA组。
我们的结果表明,与SRA肾移植相比,MRA肾移植存在风险,但在移植后第1年的结果是可接受的。